Neurocognitive Disorders

Latest News

Cognitive Impairment 3 to 12 Months After COVID-19 Hospitalization

By

Ron Goldberg

Researchers assessed the frequency and severity of cognitive impairments over time and specifically 1 year after hospitalization in patients who contracted COVID-19.

Older Adults With Hearing, Vision Impairment Increases Odds of Cognitive Decline

Hearing, vision, and dual sensory impairment are associated with cognitive impairment among older adults.

Interventions for Men, Women With Alzheimer Disease Improve Cognition

Multidomain interventions are equally effective for improving cognition in women and men.

Memory Concerns Stable, but Incidence of Cognitive Decline Increased

Rates of memory concerns among older adults remained stable, but the incidence of cognitive decline more than doubled between 2009 and 2018.

Neuroimaging Measures Linked to Stages of Memory Impairment

For cognitively unimpaired older adults, the presence of Alzheimer disease pathology is related to memory impairment.

Defining the Behavioral Variant of Alzheimer Disease

By

Mary Stroka

The authors searched PubMed/MEDLINE and Web of Science databases for studies of clinically diagnosed AD cases with frontal or behavioral presentations or bvFTD cases with neuropathological evidence of AD.

Novel Brain Imaging System Quantifies THC-Related Impairment in Cannabis Users

By

Jessica Nye, PhD

Researchers sought to evaluate the capability of a portable imaging system to effectively quantify THC impairment in cannabis users.

The Role of Cognitive Reserve on Cognitive Decline in Older Patients

By

Amit Akirov, MD

The researchers sought to explore the association between cognitive reserve indicator with global cognitive function, episodic memory, and working memory over time, and explore the role of brain pathologies in such associations.

Pimavanserin Tied to Increased Mortality in Older Adults With Parkinson Disease

By

Brandon May

Researchers sought to determine the risk of hospitalization and death associated with pimavanserin use, a novel antipsychotic medication, in adult patients 65 years and older with Parkinson disease.

Driving Habits May Help Identify Preclinical Alzheimer Disease

By

Heather R. Johnson

Investigators installed GPS data loggers with custom software in participants’ vehicles to see if driving performance could predict preclinical Alzheimer disease.